Trypanosomiasis: Clinical Trials

14 trials for Trypanosomiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 14
Phase 26Completed 6

Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases352022-07-092026-04-06
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases12082021-12-302025-03-20
Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases452019-09-292025-01-30
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Benznidazole, Placebo Oral Tablet - Chagas Disease
Phase 3CompletedTulane University School of Public Health and Tropical Medicine872019-06-012026-04-09
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 3CompletedDrugs for Neglected Diseases1742016-11-102025-01-08
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases2082016-10-112025-09-17
A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi
Nifurtimox (Lampit, BAYA2502), Placebo - Chagas Disease
Phase 3CompletedBayer3302016-01-272024-08-19
Physical Exercise Program in Chronic Chagas Heart Disease
Exercise, nutritional and pharmaceutical counceling, Nutritional and pharmaceutical counceling - Chagas Disease, Chagas Cardiomyopathy
Phase 3CompletedEvandro Chagas National Institute of Infectious Disease302015-03-012017-07-27
Cardiac Rehabilitation in Chagas Heart Failure
Exercise, nutritional and pharmaceutical counseling - Chagas Disease, Chagas Cardiomyopathy
Phase 2 / Phase 3CompletedEvandro Chagas National Institute of Infectious Disease122013-05-012015-08-05
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases3942012-10-012018-02-20
BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease
Benznidazole, Placebo - Chagas Disease, Trypanosomiasis
Phase 3CompletedPopulation Health Research Institute28542004-11-012020-03-03
Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity
Bisoprolol - Chagas Cardiomyopathy, Chronic Heart Failure
Phase 3CompletedFundación Cardiovascular de Colombia5002003-07-012010-11-24
Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial
Benznidazole, Placebo - Chagas Disease
Phase 3CompletedInstituto Nacional de Parasitologia Dr. Mario Fatala Chaben9101999-03-012015-03-11
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
Eflornithine, Nifurtimox - Trypanosomiasis, African
Phase 3CompletedDrugs for Neglected Diseases2802016-09-29

Narrower conditions

Trypanosomiasis, African (7)  ·  Chagas Disease (6)  ·  Chagas Cardiomyopathy (3)  ·  Infections (3)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Motor Activity (1)  ·  Neglected Diseases (1)

Broader conditions

Euglenozoa Infections (14)  ·  Parasitic Diseases (14)  ·  Protozoan Infections (14)  ·  Vector Borne Diseases (14)  ·  Infections (11)  ·  Cardiovascular Diseases (4)  ·  Cardiomyopathies (3)  ·  Heart Diseases (3)  ·  Behavior (1)  ·  Chagas Disease (1)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Nifurtimox (3)  ·  benzonidazole (3)  ·  fexinidazole (3)  ·  Eflornithine (2)  ·  Exercise (2)  ·  Bisoprolol (1)  ·  SCYX 7158 (1)

Sponsors

Drugs for Neglected Diseases (7)  ·  Evandro Chagas National Institute of Infectious Disease (2)  ·  Bayer (1)  ·  Fundación Cardiovascular de Colombia (1)  ·  Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben (1)  ·  Population Health Research Institute (1)  ·  Tulane University School of Public Health and Tropical Medicine (1)

Countries

Democratic Republic of the Congo (6)  ·  Argentina (4)  ·  Guinea (4)  ·  Brazil (3)  ·  Colombia (3)  ·  Bolivia (2)  ·  Republic of the Congo (2)  ·  Central African Republic (1)  ·  El Salvador (1)  ·  Malawi (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Adellina R Riarte, MD (1)  ·  Andrea S Sousa, PhD (1)  ·  Carlos A Morillo, MD, FRCPC (1)  ·  Carlos Morillo, MD (1)  ·  Digas Ngolo Tete, MPH (1)  ·  Els Torreele, PhD (1)  ·  Enock Matovu, Prof (1)  ·  Fernanda Mendes, M.D. (1)  ·  Fernando Rosas, M.D. (1)  ·  Gerardo Priotto, MD, MPH (1)  ·  Jose Antonio Marin-Neto, MD, PhD (1)  ·  Mamadou Camara, PhD (1)  ·  Pierre Buekens, MD, PhD (1)

Results publications

PMID 8937280, PMID 9790423, PMID 16235350, PMID 16702588, PMID 19559476, PMID 19753491, PMID 21264349, PMID 24867876, PMID 26323937, PMID 27590681, PMID 29113731, PMID 32831069, PMID 33412557, PMID 36460027, PMID 36975790, PMID 37352322, PMID 3835868, PMID 38589582, PMID 40288399, PMID 40288400, PMID 8273735, PMID 8948328